QBR111217

• Research type

  Research Study

• Full title

  A Phase 1, Two-Stage Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses (Stage 1) and Multiple Ascending Doses (Stage 2) of IW-9179 in Healthy Volunteers

• IRAS ID

  80111

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Ironwood Pharmaceuticals, Inc.

• Eudract number

  2011-001905-28

• Research summary

  Research Summary not published at request of researcher

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  11/IE/0061

• Date of REC Opinion

  19 May 2011

• REC opinion

  Further Information Favourable Opinion